Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Akari TherapeuticsAKTX | Open-market buy | 25/08/21–25/08/25 | 25/08/29 | 21,000 sh3 trades | $0.93avg. | $19,540 | +7.6% | |
Akari TherapeuticsAKTX | Open-market buy | 25/06/23–25/06/24 | 25/06/25 | 6,146 sh2 trades | $1.16avg. | $7,119.93 | +2.3% | |
Abizer GaslightwalaPresident & CEO | Akari TherapeuticsAKTX | Open-market buy | 25/06/20 | 25/06/24 | 10,000 sh | $1.20 | $12,000 | +3.8% |
Abizer GaslightwalaPresident & CEO | Akari TherapeuticsAKTX | Open-market buy | 25/06/17 | 25/06/20 | 15,000 sh | $1.20 | $18,000 | +6.1% |